SCHEMBL2544716

SCHEMBL2544716

NC(CCCl)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28848838 1.00
SCHEMBL30918327 1.00
Hydrochloric Acid SCHEMBL4703729 0.97
Hydrochloric Acid SCHEMBL2385511 0.97
SCHEMBL29268469 0.84
SCHEMBL5287112 0.82 GSR (0.64)
SCHEMBL602426 0.82 GSR (0.68)
SCHEMBL8068164 0.82 GSR (0.68)
SCHEMBL23214374 0.80 GSR (0.61)
Hydrochloric Acid SCHEMBL11434603 0.80 GSR (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117343098-A Method for preparing glufosinate-ammonium by taking methyl dichlorophosphine as raw material 内蒙古犇星化学有限公司 2024-01-05 CN claimed
CN-118950081-A Catalyst for synthesizing L-glufosinate-ammonium, and preparation method and application thereof 山东汇盟生物科技股份有限公司 2024-11-15 CN disclosed
CN-117343098-A Method for preparing glufosinate-ammonium by taking methyl dichlorophosphine as raw material 内蒙古犇星化学有限公司 2024-01-05 CN disclosed
CN-117343098-A Method for preparing glufosinate-ammonium by taking methyl dichlorophosphine as raw material 内蒙古犇星化学有限公司 2024-01-05 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20130130985-A1 OXYTOCIN PEPTIDE ANALOGUES THE UNIVERSITY OF QUEENSLAND (AU) 2013-05-23 US disclosed
WO-2011120071-A1 OXYTOCIN PEPTIDE ANALOGUES THE UNIVERSITY OF QUEENSLAND (AU) 2011-10-06 WO disclosed
US-20090180958-A1 Diagnostic and therapeutic agents KARYON-CTT LTD. (FI) 2009-07-16 US disclosed
CN-101184769-A Diagnostic and therapeutic agents KARYON CTT LTD (FI) 2008-05-21 CN disclosed
EP-1874800-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS Karyon-CTT Ltd (FI) 2008-01-09 EP disclosed
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed
WO-2006114478-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2006-11-02 WO disclosed
JP-2002080436-A γ-CHLORO-α-AMINO BUTYRIC ACID DERIVATIVE, METHOD FOR PRODUCING THE SAME AND METHOD FOR USING THE SAME HOECHST AG 2002-03-19 JP disclosed
US-5442088-A Reacting optically active S-homoserine lactone with hydrogen chloride in the presence of an alcohol, and reacting the resulting halogen substituted compound with a phosphorus compound HOECHST AKTIENGESELLSCHAFT (DE) 1995-08-15 US disclosed
US-4142061-A FOR STABILIZING COBALT CABONYL CATALYST CHEVRON RESEARCH COMPANY (US) 1979-02-27 US disclosed
US-4096191-A Hydroformylation of olefins using azoxy-dentated ligands CHEVRON RESEARCH COMPANY (US) 1978-06-20 US disclosed
US-4071405-A BETA- OR GAMMA-AMINO ACIDS, METHIONINASE AJINOMOTO CO., INC. (JA) 1978-01-31 US disclosed
US-3983048-A Composition for accelerating oxygen removal comprised of a mixture of aqueous hydrazine and an aryl amine compound OLIN CORPORATION (US) 1976-09-28 US disclosed